Researchers have discovered that a widely used class of drugs may be beneficial to acute myeloid leukaemia (AML) patients who are resistant to a common treatment.
According to the Swedish study, ribonucleotide reductase inhibitors – which include...
4 years ago
Researchers have used genomic sequencing to analyse patterns of neoantigens in multiple myeloma patients, with a view to developing improved immunotherapy.
Neoantigens are by-products from gene mutations in tumours that have not yet been recognise...
4 years ago
